⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10525261 | 1.00 | — | — | |
| SCHEMBL10524681 | 0.85 | — | — | |
| SCHEMBL10002105 | 0.85 | — | — | |
| SCHEMBL10524556 | 0.84 | CCNB2 (0.32) | — | |
| SCHEMBL8907704 | 0.84 | CCNB2 (0.32) | — | |
| SCHEMBL15178544 | 0.78 | — | — | |
| SCHEMBL8082647 | 0.77 | KDM4E (0.31) | — | |
| SCHEMBL17424888 | 0.76 | — | — | |
| SCHEMBL12373844 | 0.73 | — | — | |
| SCHEMBL15204788 | 0.73 | MAOA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0337601-A1 | Porphyrins and medicaments for cancer treatment | SCOTIA HOLDINGS PLC (GB) | 1989-10-18 | — | — | EP | claimed |
| US-7319147-B2 | Porphyrins and related compounds | BIOSCIENCE TECHNOLOGY INVESTMENT HOLDINGS LIMITED (MY) | 2008-01-15 | — | — | US | disclosed |
| US-20060040913-A1 | Porphyrins and related compounds | BIOSCIENCE TECHNOLOGY INVESTMENT HOLDINGS LIMITED (MY) | 2006-02-23 | — | — | US | disclosed |
| EP-1250339-B1 | PORPHYRINS AND RELATED COMPOUNDS | BIOSCIENCE TECHNOLOGY INVEST H (MY) | 2003-09-03 | — | — | EP | disclosed |
| EP-1250339-A1 | PORPHYRINS AND RELATED COMPOUNDS | SCOTIA HOLDINGS PLC (GB) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001053300-A1 | PORPHYRINS AND RELATED COMPOUNDS | SCOTIA HOLDINGS PLC (GB) | 2001-07-26 | — | — | WO | disclosed |